<![CDATA[Vamorolone’s Cardiac Rationale in Duchenne Muscular Dystrophy]]>
In this episode, Carol Wittlieb-Weber, MD, provides cardiology context for why vamorolone’s pharmacologic profile is generating interest beyond skeletal muscle outcomes. She explains the role of aldosterone and mineralocorticoid receptor signaling in heart …